116 related articles for article (PubMed ID: 1708430)
1. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
Uemura Y; Niiya K; Takeuchi T; Miyoshi I
Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
[TBL] [Abstract][Full Text] [Related]
2. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
[TBL] [Abstract][Full Text] [Related]
3. [Non-hemophilic patient with inhibitor against factor VIII produced after the second delivery].
Akahori M; Yamane T; Hino M; Ohta K; Takubo T; Samori T; Tatsumi N
Rinsho Byori; 1999 Sep; 47(9):891-5. PubMed ID: 10518429
[TBL] [Abstract][Full Text] [Related]
4. [Examination of the inhibitor to factor VIII in non-haemophilic patient].
Suetomo M; Suehisa E; Nishimura K; Toyokawa M; Toku M; Fushimi R; Amino N; Miyai K; Izumi M; Ohtsuka A
Rinsho Byori; 1991 Jul; 39(7):748-52. PubMed ID: 1920868
[TBL] [Abstract][Full Text] [Related]
5. [Remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with infusion of factor VIII and corticosteroid].
Honda J; Egami K; Osabe S; Natori H; Nakamura E; Tanaka K; Naitou K; Kaji M
Rinsho Ketsueki; 1989 Apr; 30(4):520-4. PubMed ID: 2504978
[TBL] [Abstract][Full Text] [Related]
6. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
[TBL] [Abstract][Full Text] [Related]
7. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
[TBL] [Abstract][Full Text] [Related]
8. [Immunoblotting analysis of acquired factor VIII inhibitor in an elderly man].
Kikuchi M; Sano M; Shimamoto Y; Yamaguchi M; Tadano J; Takahashi I; Kamiya T
Rinsho Ketsueki; 1993 Jul; 34(7):876-8. PubMed ID: 7689663
[TBL] [Abstract][Full Text] [Related]
9. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
10. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
11. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
12. Clinical patterns of hemophilic patients who develop inhibitors.
McMillan CW
Prog Clin Biol Res; 1984; 150():31-44. PubMed ID: 6431436
[TBL] [Abstract][Full Text] [Related]
13. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.
Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H
Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391
[TBL] [Abstract][Full Text] [Related]
14. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
[TBL] [Abstract][Full Text] [Related]
16. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
[TBL] [Abstract][Full Text] [Related]
17. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome.
Yamamoto K; Niiya K; Shigematu T; Kiguchi T; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Shima M; Harada M
Int J Hematol; 2000 Dec; 72(4):517-9. PubMed ID: 11197224
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
[TBL] [Abstract][Full Text] [Related]
19. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
[TBL] [Abstract][Full Text] [Related]
20. [The antiphospholipid syndrome during chronic lymphatic leukemia. An association with anti-factor VIII antibodies].
Ghirarduzzi A; Silingardi M; D'Incà M; Tincani E
Ann Ital Med Int; 1999; 14(1):46-50. PubMed ID: 10528424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
